Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 68

1.

Starting insulin therapy in type 2 diabetes: twice-daily biphasic insulin Aspart 30 plus metformin versus once-daily insulin glargine plus glimepiride.

Kann PH, Wascher T, Zackova V, Moeller J, Medding J, Szocs A, Mokan M, Mrevlje F, Regulski M.

Exp Clin Endocrinol Diabetes. 2006 Oct;114(9):527-32.

PMID:
17115351
[PubMed - indexed for MEDLINE]
2.

Biphasic insulin aspart 30: literature review of adverse events associated with treatment.

Davidson J, Vexiau P, Cucinotta D, Vaz J, Kawamori R.

Clin Ther. 2005;27 Suppl B:S75-88. Review.

PMID:
16519039
[PubMed - indexed for MEDLINE]
3.

Efficacy of biphasic insulin aspart in patients with type 2 diabetes.

Halimi S, Raskin P, Liebl A, Kawamori R, Fulcher G, Yan G.

Clin Ther. 2005;27 Suppl B:S57-74. Review.

PMID:
16519038
[PubMed - indexed for MEDLINE]
4.

Insulin glargine: a systematic review of a long-acting insulin analogue.

Wang F, Carabino JM, Vergara CM.

Clin Ther. 2003 Jun;25(6):1541-77, discussion 1539-40. Review.

PMID:
12860485
[PubMed - indexed for MEDLINE]
5.

Biphasic insulin aspart in type 2 diabetes mellitus: an evidence-based medicine review.

Gough SC, Tibaldi J.

Clin Drug Investig. 2007;27(5):299-324. Review.

PMID:
17451279
[PubMed - indexed for MEDLINE]
6.

Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.

Ilag LL, Kerr L, Malone JK, Tan MH.

Clin Ther. 2007 Jun;29(6 Pt 1):1254-70. Review.

PMID:
18036388
[PubMed - indexed for MEDLINE]
7.

Biphasic insulin aspart in the treatment of type 2 diabetes mellitus.

Cucinotta D, Russo GT.

Expert Opin Pharmacother. 2009 Dec;10(17):2905-11. doi: 10.1517/14656560903391714. Review.

PMID:
19929709
[PubMed - indexed for MEDLINE]
8.

Premixed insulin analogues for the treatment of diabetes mellitus.

Garber AJ.

Drugs. 2006;66(1):31-49. Review.

PMID:
16398567
[PubMed - indexed for MEDLINE]
9.

Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis.

Gross JL, Kramer CK, Leitão CB, Hawkins N, Viana LV, Schaan BD, Pinto LC, Rodrigues TC, Azevedo MJ; Diabetes and Endocrinology Meta-analysis Group (DEMA).

Ann Intern Med. 2011 May 17;154(10):672-9. doi: 10.7326/0003-4819-154-10-201105170-00007. Review.

PMID:
21576535
[PubMed - indexed for MEDLINE]
10.

Clinical inquiries. What is the role of combination therapy (insulin plus oral medication) in type 2 diabetes?

Eskesen S, Kelsberg G, Hitchcock K, Lo V.

J Fam Pract. 2006 Nov;55(11):1001-3. Review.

PMID:
17090364
[PubMed - indexed for MEDLINE]
11.

Practical approaches to insulin therapy for type 2 diabetes mellitus with premixed insulin analogues.

Rolla AR, Rakel RE.

Clin Ther. 2005 Aug;27(8):1113-25. Review.

PMID:
16199240
[PubMed - indexed for MEDLINE]
12.

Timely initiation of basal insulin.

Riddle MC.

Am J Med. 2004 Feb 2;116 Suppl 3A:3S-9S. Review.

PMID:
15013454
[PubMed - indexed for MEDLINE]
13.

Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses.

Lasserson DS, Glasziou P, Perera R, Holman RR, Farmer AJ.

Diabetologia. 2009 Oct;52(10):1990-2000. doi: 10.1007/s00125-009-1468-7. Epub 2009 Jul 31. Review.

PMID:
19644668
[PubMed - indexed for MEDLINE]
14.

Increase of body weight during the first year of intensive insulin treatment in type 2 diabetes: systematic review and meta-analysis.

Pontiroli AE, Miele L, Morabito A.

Diabetes Obes Metab. 2011 Nov;13(11):1008-19. doi: 10.1111/j.1463-1326.2011.01433.x. Review.

PMID:
21645195
[PubMed - indexed for MEDLINE]
15.

Relationship of insulin dose, A1c lowering, and weight in type 2 diabetes: comparing insulin glargine and insulin detemir.

Dailey G, Admane K, Mercier F, Owens D.

Diabetes Technol Ther. 2010 Dec;12(12):1019-27. doi: 10.1089/dia.2010.0063. Review.

PMID:
21128849
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Practical guidance on intensification of insulin therapy with BIAsp 30: a consensus statement.

Unnikrishnan AG, Tibaldi J, Hadley-Brown M, Krentz AJ, Ligthelm R, Damci T, Gumprecht J, Gero L, Mu Y, Raz I.

Int J Clin Pract. 2009 Nov;63(11):1571-7. doi: 10.1111/j.1742-1241.2009.02192.x. Epub 2009 Sep 19.

PMID:
19780866
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

[Combination treatment with insulin and metformin in type 2 diabetes. Improves glycemic control and prevents weight gain].

Hermann LS, Melander A.

Lakartidningen. 1999 Dec 15;96(50):5616-9. Review. Swedish.

PMID:
10643226
[PubMed - indexed for MEDLINE]
18.

Efficacy and safety comparison of rapid-acting insulin aspart and regular human insulin in the treatment of type 1 and type 2 diabetes mellitus: a systematic review.

Rys P, Pankiewicz O, Łach K, Kwaskowski A, Skrzekowska-Baran I, Malecki MT.

Diabetes Metab. 2011 Jun;37(3):190-200. doi: 10.1016/j.diabet.2010.12.003. Epub 2011 Feb 17. Review.

PMID:
21333580
[PubMed - indexed for MEDLINE]
Free Article
19.

[Continuation 50. Type 2 diabetes: possibilities and limitations of pharmacological therapy].

Kellerer M, Jakob S, Linn T, Haslbeck M.

MMW Fortschr Med. 2003 Dec 18;145(51-52):I-X; quiz XI-XII. Review. German. No abstract available.

PMID:
14974337
[PubMed - indexed for MEDLINE]
20.

Basal insulin supplementation in type 2 diabetes; refining the tactics.

Rosenstock J.

Am J Med. 2004 Feb 2;116 Suppl 3A:10S-16S. Review.

PMID:
15013455
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk